(Q52072146)
Statements
1 reference
A phase I clinical and pharmacokinetic study of the dolastatin analogue cemadotin administered as a 5-day continuous intravenous infusion. (English)
1 reference
Supko JG
1 reference
Lynch TJ
1 reference
Clark JW
1 reference
Fram R
1 reference
Allen LF
1 reference
Velagapudi R
1 reference
Kufe DW
1 reference
Eder JP Jr
1 reference
1 January 2000
1 reference
46
1 reference
4
1 reference
319-328
1 reference
Identifiers
1 reference
1 reference